KAPA

Kairos Pharma (KAPA)

About Kairos Pharma (KAPA)

Kairos Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of novel and transformative drug therapies to treat cancer. It focuses on the research and development of immunotherapies for oncology. The company was founded by John S. Yu on June 17, 2013 and is headquartered in Los Angeles, CA.

Details

Daily high

$0.76

Daily low

$0.72

Price at open

$0.74

52 Week High

$3.25

52 Week Low

$0.40

Market cap

15.4M

Dividend yield

0.00%

Volume

112,689

Avg. volume

131,488

P/E ratio

-2.44

Kairos Pharma News